Investing Profile

Arjun Goyal

InvestorVC
Co-Founder and Managing Director at Vida Ventures, LLC
vidaventures.com/vida-team/Boston, Massachusetts
Photo of Arjun Goyal, Managing Director at Vida Ventures, LLC

Signal uses Gmail to reveal intro paths. Email content is never read.

Sign in with Google →
Harvard Business School Network
631 CONNECTIONS
University of Oxford Network
274 CONNECTIONS
University of Oxford Network
274 CONNECTIONS
University of Cambridge Network
260 CONNECTIONS
Office of US Senator Daniel Patrick Moynihan Network
132 CONNECTIONS
cb
Vida Ventures, LLC Managing Director
$100K - $10.0M
$1M
13
CompanyStageDateRound SizeTotal Raised
Halda Therapeutics
Series BAug 2024$130M
$200M
Co-investors: Tim Shannon (Canaan Partners)
Third Arc Bio
Series AJul 2024$170M
$220M
Co-investors: Jorge Conde (Andreessen Horowitz)
Scorpion Therapeutics
Series CJul 2024$150M
Series BJan 2021$160M
Series AOct 2020$110M
$420M
Co-investors: Paulina Hill (Polaris Partners), Jean-François Formela (Atlas Venture), Albert Cha (Vivo Capital)
Alterome Therapeutics
Series BApr 2024$130M
Series AJan 2022$64M
$230M
Co-investors: Thilo Schroeder (Nextech Invest), Carl Gordon (OrbiMed Advisors)
Quanta Therapeutics
Series DMay 2023$51M
Series COct 2021$60M
$110M
Co-investors: Maha Katabi (Sofinnova Investments)
Affini-T Therapeutics
Series UnknownMar 2022$180M
$180M
Centessa Pharmaceuticals
Series AFeb 2021$250M
$250M
Co-investors: Brett Zbar (General Atlantic)
Allogene Therapeutics
Series AApr 2018$410M
$410M
Co-investors: Arie Belldegrun (Vida Ventures, LLC), Stefan Vitorovic (Vida Ventures)
Resident (Oncology) Office of US Senator Daniel Patrick MoynihanPresent
Life Sciences M&A MBA Summer Associate LazardPresent
Principal 5AM VenturesPresent
Board Observer Cleave Therapeutics, Inc.Present
Interim Vice President, Corporate Development Pear TherapeuticsPresent
Board Observer and Founding Team Office of US Senator Daniel Patrick MoynihanPresent
Board Observer Spyryx BiosciencesPresent
Board Observer Portal InstrumentsPresent
Board Observer Pear TherapeuticsPresent
Board Observer Aprea TherapeuticsPresent
Board Observer and Founding Team Entrada TherapeuticsPresent
Member Board Of Directors Pionyr ImmunotherapeuticsPresent
Investor AskBio Inc.Present
Investor Office of US Senator Daniel Patrick MoynihanPresent
Member Board Of Directors Kinnate Biopharma Inc.Present
Member Board Of Directors Scorpion TherapeuticsPresent
Member Board Of Directors Quanta TherapeuticsPresent
Member Board Of Directors Centessa PharmaceuticalsPresent
Member Board Of Directors Alterome Therapeutics, IncPresent
Venture Capital Advisor & Program Advisor MS/ MBA Life Sciences Program Harvard Business SchoolPresent
Member Board of Directors Halda TherapeuticsPresent
Co-Founder Office of US Senator Daniel Patrick MoynihanPresent
Co-Founder and Managing Director Vida Ventures, LLCPresent
Co-Founder and Board Member Affini-T TherapeuticsPresent
Founder and Managing Partner Vianti CapitalPresent
University of Melbourne Bachelor of Medicine, Bachelor of Surgery (MBBS - MD equivalent) & Diploma in French Medicine & French
University of Melbourne Bachelor of Medicine Bachelor of Surgery (MBBS - MD equivalent) & Diploma in French, Medicine & French
University of Oxford Bachelor Medical Science Magdalen College
University of Oxford Bachelor Medical Science Malaria Vaccine Development
University of Cambridge Master of Philosophy Bioscience Enterprise
Harvard Business School MBA Business Administration
Sign in with Google →
Sign in with Google →